Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01193998 · ClinicalTrials.gov registry record · NA

Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department

A NA study of Dyspnea and Acute Heart Failure, sponsored by Unity Health Toronto.

Completed
Registry status
NA
Development phase
186
Enrollment target
3
Study locations

NCT01193998: Completed NA study of Dyspnea and Acute Heart Failure, sponsored by Unity Health Toronto.

NCT01193998 is a NA study of Dyspnea and Acute Heart Failure that has completed, run by Unity Health Toronto. The registered enrollment target is 186 participants, below the 297-participant average among 23 other Dyspnea trials with a reported enrollment target (37% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01193998, a NA study of Dyspnea and Acute Heart Failure, has completed, sponsored by Unity Health Toronto.

COMPLETED
Registry status
NA
Development phase
186 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to evaluate a validated diagnostic prediction model in the appropriate diagnosis of Acute Heart Failure (AHF) in patients presenting at the emergency department with undifferentiated dyspnea.

Interventions

  • OTHER Treatment as per model probability
  • OTHER Treatment as per usual care

Study Locations (3)

Michigan

  • Wayne State University - Detroit

Ontario

  • St. Michael's Hospital - Toronto

Other

  • Waikato Hospital Cardiology Clinical Trials Unit - Waikato

Trial Details

FieldValue
Enrollment Target 186 participants
Start Date 2010-09
Est. Completion 2014-06
Phase NA
Unity Health Toronto

12 total trials

What the finished NCT01193998 record still lists

NCT01193998 is an interventional study that assigns participants to a tested intervention. The registered 186 participants enrollment target is mid-sized for trials with a published cap, below the 297-participant average among 23 other Dyspnea trials with a reported enrollment target (37% lower).

The record links to 3 conditions, with Dyspnea appearing as the primary indexed condition, and to 2 interventions - of which Treatment as per model probability is the first listed.

NCT01193998 reports a single indexed study location in Michigan, Ontario, Other.

Frequently Asked Questions

What is clinical trial NCT01193998 about?

NCT01193998 is a clinical study titled "Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department". The purpose of this study is to evaluate a validated diagnostic prediction model in the appropriate diagnosis of Acute Heart Failure (AHF) in patients presenting at the emergency department with undifferentiated dyspnea.

What is the current status of trial NCT01193998?

This trial is currently completed. It is a NA study. The enrollment target is 186 participants. The study started on 2010-09. Estimated completion is 2014-06.

What conditions does trial NCT01193998 study?

This clinical trial studies the following conditions: Dyspnea, Acute Heart Failure, Shortness of Breath.

What interventions are being tested in trial NCT01193998?

The interventions under investigation include: Treatment as per model probability (OTHER), Treatment as per usual care (OTHER).

Who is sponsoring clinical trial NCT01193998?

This trial is sponsored by Unity Health Toronto, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01193998 being conducted?

This trial has 3 study locations across Michigan, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dyspnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01193998's enrollment target sits among peer trials

186 5th of 23 higher than 19 of 23 other Dyspnea trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dyspnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03567889 · 186 participants · Phase 3

    Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

  • NCT05281471 · 186 participants · Phase 3

    Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

  • NCT05405595 · 186 participants · Phase 1

    ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

  • NCT05762107 · 186 participants · Phase 2

    A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01193998, the US trial registry maintained by the National Library of Medicine. NCT01193998 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.